Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab in advanced cutaneous squamous cell carcinoma
NCT03834233Phase 2Unknown
- Sponsor
- Instituto do Câncer do Estado de São Paulo
- Start
- Sep 2019
- Primary completion
- Dec 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in cutaneous squamous cell carcinoma (cSCC), sponsored by Instituto do Câncer do Estado de São Paulo. Status: unknown.
02
Drugs
03
Conditions
cutaneous squamous cell carcinoma (cSCC)
Beyond the preview
Go deeper on NCT03834233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03834233.